X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (174) 174
humans (173) 173
endocrinology & metabolism (136) 136
animals (131) 131
female (130) 130
mice (124) 124
middle aged (111) 111
diabetes (87) 87
type 2 diabetes (87) 87
aged (84) 84
insulin (81) 81
insulin resistance (72) 72
chemistry (70) 70
glucose (70) 70
metallurgy (68) 68
adult (64) 64
diabetes mellitus (62) 62
diabetes mellitus, type 2 - drug therapy (56) 56
human necessities (55) 55
mice, knockout (55) 55
mice, inbred c57bl (52) 52
organic chemistry (47) 47
hygiene (46) 46
medical or veterinary science (46) 46
original (45) 45
research (43) 43
preparations for medical, dental, or toilet purposes (42) 42
hypoglycemic agents - therapeutic use (41) 41
specific therapeutic activity of chemical compounds ormedicinal preparations (41) 41
heterocyclic compounds (39) 39
original article (39) 39
diabetes mellitus, type 2 - blood (37) 37
expression (34) 34
insulin-resistance (34) 34
treatment outcome (34) 34
japan (33) 33
blood glucose - metabolism (32) 32
mellitus (32) 32
obesity (32) 32
risk factors (32) 32
body weight (31) 31
insulin receptor substrate proteins (31) 31
performing operations (30) 30
transporting (30) 30
type 2 diabetes mellitus (30) 30
biochemistry & molecular biology (29) 29
glucose - metabolism (28) 28
insulin - metabolism (28) 28
resistance (27) 27
liver (26) 26
hypoglycemia (25) 25
sitagliptin (25) 25
hemoglobin (24) 24
secretion (24) 24
care and treatment (23) 23
glycemic control (23) 23
phosphoproteins - genetics (23) 23
risk (23) 23
textiles (23) 23
blood glucose - analysis (22) 22
glycated hemoglobin a - analysis (22) 22
medicine & public health (22) 22
peptides (22) 22
signal transduction (22) 22
adiponectin (21) 21
hypoglycemic agents - administration & dosage (21) 21
liver - metabolism (21) 21
physiological aspects (21) 21
retrospective studies (21) 21
body mass index (20) 20
drug administration schedule (20) 20
glycated hemoglobin a - metabolism (20) 20
metabolism (20) 20
miglitol (20) 20
vehicles in general (20) 20
analysis (19) 19
diagnosis (19) 19
disease models, animal (19) 19
glucagon-like peptide-1 (19) 19
glucose tolerance test (19) 19
glycosylated hemoglobin (19) 19
insulin - blood (19) 19
multidisciplinary sciences (19) 19
oncology (19) 19
time factors (19) 19
blasting (18) 18
diabetes-mellitus (18) 18
heating (18) 18
hyperglycemia (18) 18
insulin secretion (18) 18
lighting (18) 18
mechanical engineering (18) 18
phosphorylation (18) 18
ppar-gamma (18) 18
therapy (18) 18
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (18) 18
weapons (18) 18
aged, 80 and over (17) 17
biochemistry (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (752) 752
Japanese (89) 89
French (34) 34
German (22) 22
Chinese (8) 8
Portuguese (3) 3
Spanish (3) 3
Korean (2) 2
Russian (2) 2
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Italian (1) 1
Polish (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular diabetology, ISSN 1475-2840, 2014, Volume 13, Issue 1, p. 65
Journal Article
Journal of Diabetes Investigation, ISSN 2040-1116, 03/2017, Volume 8, Issue 2, pp. 149 - 151
Glucose‐ or insulin resistance‐mediated β‐cell replication serves as a useful physiological model of β‐cell mass expansion to study the pathophysiology of type... 
Diabetes Mellitus, Type 2 | Insulin-Secreting Cells - cytology | Animals | Glucose | Mice, Inbred C57BL | Insulin Resistance | Cell proliferation | Obesity | Protein kinase C | Diabetes mellitus | Transgenic mice | Kinases | Insulin | Hyperglycemia | Autopsy | Rodents | Insulin resistance | Replication | Diabetes mellitus (non-insulin dependent) | Commentaries
Journal Article
Scientific reports, ISSN 2045-2322, 2019, Volume 9, Issue 1, pp. 16180 - 12
Journal Article
Journal Article
Endocrine journal, ISSN 0918-8959, 2016, Volume 63, Issue 2, pp. 135 - 142
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 2011, Volume 60, Issue 4, pp. 1246 - 1257
Journal Article
Journal of gastroenterology, ISSN 1435-5922, 2007, Volume 42, Issue 7, pp. 573 - 582
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2018, Volume 20, Issue 2, pp. 378 - 388
Aims To assess the safety and efficacy of monotherapy with once‐weekly subcutaneous (s.c.) semaglutide vs sitagliptin in Japanese people with type 2 diabetes... 
GLP‐1 | sitagliptin | type 2 diabetes | GLP-1 | METFORMIN | ADD-ON | AMERICAN ASSOCIATION | HUMAN GLP-1 ANALOG | EXENATIDE | PHASE 3A | OPEN-LABEL | CLINICAL ENDOCRINOLOGISTS | LIRAGLUTIDE | ENDOCRINOLOGY & METABOLISM | ACUTE-PANCREATITIS | Glycated Hemoglobin A - analysis | Follow-Up Studies | Nausea - chemically induced | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Diarrhea - physiopathology | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glucagon-Like Peptides - administration & dosage | Humans | Nausea - physiopathology | Patient Dropouts | Weight Loss - drug effects | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Hypoglycemia - prevention & control | Diabetes Mellitus, Type 2 - ethnology | Glucagon-Like Peptide-1 Receptor - metabolism | Nausea - therapy | Injections, Subcutaneous | Hypoglycemia - chemically induced | Severity of Illness Index | Sitagliptin Phosphate - administration & dosage | Hyperglycemia - prevention & control | Drug Administration Schedule | Administration, Oral | Japan | Constipation - physiopathology | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Constipation - chemically induced | Glucagon-Like Peptides - adverse effects | Diabetes Mellitus, Type 2 - blood | Diarrhea - therapy | Constipation - therapy | Incretins - adverse effects | Sitagliptin Phosphate - therapeutic use | Glucagon-Like Peptides - therapeutic use | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Incretins - administration & dosage | Sitagliptin Phosphate - adverse effects | Type 2 diabetes | Glycosylated hemoglobin | Hypoglycemic agents | Glucagon | Diabetes mellitus | Body weight | Hemoglobin | Diabetes | Safety | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Original
Journal Article